Regardless, given the important role for monocyte infiltration into sites of infection and tumour growth [54], our results indicate that manipulation of the LIGHT-LTβR signalling axis offers a potential way to improve monocyte mobilisation for therapeutic applications. The gene discussed is LTBR; the disease is neoplasm.